Schiff, the parent brand of Move Free, has accumulated over 85 years of expertise in researching and producing professional dietary supplements backed by rigorous scientific research. In addition, it has established the Scientific and Innovation Advisory Committee, comprising distinguished experts who contribute invaluable insights and knowledge, securing the scientific rigor of the research and production processes for Move Free products.
The committee is composed of leading experts in various scientific domains, including experts in microbiome, brain health, nutritional genomics and personalized nutrition, omega-3 fatty acids, public health nutrition, and dietary supplements. This diverse group of thought leaders provides invaluable insights that shape our product innovation and keep our team updated on the latest scientific advancements in nutrition and health.
Dr. Regan Bailey is a distinguished professor in the Department of Nutritional Science at Purdue University. She also holds leadership roles as the director of the Indiana Clinical and Translational Science Institute and the Purdue Diet Assessment Center. Before joining Purdue University, Dr. Bailey served as a nutritional epidemiologist and career development and outreach director at the NIH Office of Dietary Supplements. Dr. Bailey is a registered dietitian. She completed her dietetic internship and earned a Master's degree in Food and Nutrition at Indiana University of Pennsylvania. She pursued her Ph.D. in Nutritional Sciences at Pennsylvania State University and obtained a Master of Public Health degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Bailey's research is focused on improving methods for measuring nutritional status to promote optimal health outcomes. She uses nationally representative survey data to analyze American dietary patterns, optimize nutritional status biomarker techniques, and importantly, explore the intricate relationship between dietary intake and health outcomes. She is the author of over 130 peer-reviewed scientific publications and was recently elected to the National Academy of Medicine for her significant contributions to nutritional research.
Dr. David Chernoff brings extensive experience to his role as a chief medical officer at SetPoint Medical, having previously held the same position at Schiff Nutrition and OLLY. With a background in molecular diagnostics and biopharmaceutical industries, Dr. Chernoff has been instrumental in driving early-stage development programs and evaluating a wide range of licensing opportunities for successful clinical development and product commercialization. Throughout his career, Dr. Chernoff has served as a translational medicine consultant for over 40 biotechnology, pharmaceutical, and medical device companies. He has held Chief Medical Officer positions at numerous companies including Crescendo Bioscience, Adamas Pharma, XDX, CardioDX, Tethys Biosciences, and Aquinox Pharma, and served as Vice President of Corporate Technology at Elan Pharmaceuticals. Notably, he has also contributed significantly to the development of HIV, HCV, HBV, and CMV viral load testing during his time as Medical Director at Chiron Diagnostics. In addition, he has been involved as head of the life science management consulting company Keelin Reeds Ventures, as well as the entrepreneur-in-residence and operating partner at TPG Biotech VC Fund.
Dr. Suzanne Devkota serves as the Director of Microbiome Research at Cedars-Sinai Medical Center in Los Angeles, and is an Assistant Professor of Medicine at the University of California, Los Angeles, focusing on investigating the role of the gut microbiome in inflammatory bowel disease. Through her research, Dr. Devkota has made significant contributions to understanding the impact of diet on host-microbe interactions, which has led to insights into the mechanisms behind the rapid increase of diseases such as inflammatory bowel disease over the past century. Her current research focuses on the role of pathogens (symbiotic microorganisms that can become pathogenic under certain selective pressures) in host immune responses and the effects of counteractive nutritional therapies. Dr. Devkota received her bachelor's degrees in Biology and Chemistry from Urbana-Champaign, followed by a master's degree in Nutritional Sciences from the same university. She completed her Ph.D. in Molecular Metabolism and Nutrition at the University of Chicago, focusing on gastroenterology and the emerging field of the microbiome. During her postdoctoral training at the Joslin Diabetes Center at Harvard Medical School, Dr. Devkota further honed her expertise in microbiome research. She is an alumna of the Branco Weiss Fellowship.
Dr. William Harris is a professor of Internal Medicine at the Sanford School of Medicine, University of South Dakota, founder of OmegaQuant Analytics, LLC, and president of the newly established Fatty Acid Research Institute. He earned his Ph.D. in Human Nutrition from the University of Minnesota and conducted postdoctoral research focusing on Clinical Nutrition and Lipid Metabolism. One of Dr. Harris's notable contributions is co-inventing and defining the Omega-3 Index, a standardized method for analyzing Omega-3 fatty acids. This method has been widely used in hundreds of studies and has been tested in millions of patients. He has received five grants from NIH to investigate the effects of Omega-3 fatty acids (EPA and DHA) on human health and has authored over 300 publications on Omega-3 fatty acids in the medical literature.
Dr. José Ordovás is a senior scientist and director of the Nutrition and Genomics Laboratory at the JM-USDA Human Nutrition Research Center on Aging at Tufts University. Additionally, he is a professor of nutrition at the Friedman School of Nutrition Science and Policy, as well as a professor of genetics and pharmacology at the Graduate School of Biomedical Sciences of Tufts. Dr. Ordovás's research focuses on the genetic factors contributing to susceptibility to heart disease and obesity, along with their interactions with environmental and behavioral factors. He has published over 850 scientific articles in peer-reviewed journals, authored numerous books and book chapters, and has spoken at hundreds of international conferences, workshops, and courses related to precision nutrition.
Dr. Gary Small holds the position of director of Behavioral Health at the Hackensack Meridian Health Center and serves as the chair of Psychiatry at the Hackensack University Medical Center. He is also a professor emeritus of Psychiatry and Behavioral Sciences at the University of California, Los Angeles. With a prolific career, Dr. Small has written over 500 scientific publications and 10 books, notably including The Memory Bible, which became a New York Times bestseller. He is a sought-after lecturer globally, sharing insights from his research. His research is frequently featured in reputable media outlets including The New York Times, The Wall Street Journal, The Times of London, The Washington Post, Time, Newsweek, and numerous television programs. Dr. Small has also received numerous awards and honors, including the Jack Weinberg Award from the American Psychiatric Association and being named one of the Top 50 Global Innovators by Scientific American.
